what a great story..., page-5

To my mind this company has enormous potential in the feilds that are going to become increasingly more important (cartilage replacement, heart repair and bone repair) in an aging population. The only problem I see is the time it will take to get them to market. From the news casts it seemed that the use of the therapies was imminent,but on their web site MSB says that it will be in the order of 3 years to market. This is a long time and probably a couple of capital raisings away and I don't know if it will be worth it in the end. I have watched something similar with my shares in PGL. I hope these perform better.